NAPSR News: Sanofi Acquires Rights to MannKind’s AFREZZA® (Inhaled Insulin)

Industry leader Sanofi and MannKind Corp have agreed to a enter into a global licensing agreement to develop and market AFREZZA® (Insulin human) rapid- acting inhaled insulin.



via Marketing - United States - Latest News http://ift.tt/1sV55aM